Related Experiment Video

Updated: Jul 10, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.1K

Encapsulation protocol for fecal microbiota transplantation

Dávid Sipos1, Adorján Varga2, Ágnes Kappéter1

  • 11st Department of Internal Medicine - Department of Infectology, University of Pécs Clinical Centre, Pécs, Hungary.

Frontiers in Cellular and Infection Microbiology
|July 11, 2024
PubMed
Abstract

Insights

Fecal microbiota transplantation (FMT) using encapsulated lyophilized stool is effective for treating Clostridioides difficile infections (CDI). Encapsulated FMT showed a high success rate, particularly with reduced bacterial counts, offering improved compliance and storage.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Infectious Diseases

Background:

  • Clostridioides difficile infections (CDI) present a significant clinical challenge.
  • Fecal microbiota transplantation (FMT) is an established and effective treatment for recurrent CDI.
  • Emerging research indicates FMT's potential therapeutic applications beyond CDI.

Purpose of the Study:

  • To introduce a novel protocol for encapsulating lyophilized fecal material for FMT.
  • To enhance patient compliance, flexibility, storage, and safety of FMT procedures.

Main Methods:

  • Development of a new protocol for encapsulating lyophilized fecal matter.
  • Administration of encapsulated FMT to 28 patients diagnosed with CDI.
  • Comparison of treatment outcomes based on bacterial counts in the capsules.

Main Results:

  • An overall success rate of 82.14% was achieved using encapsulated lyophilized stool for FMT.
  • Patients receiving capsules with reduced bacterial counts demonstrated a higher success rate of 93.75%.
  • The novel encapsulation method improved compliance, flexibility, storage, and safety.

Conclusions:

  • Encapsulated FMT is a viable and effective treatment for CDI.
  • Further research is needed to elucidate the precise mechanisms of action of FMT.
  • This protocol facilitates broader clinical application and research into FMT.
Keywords:
Clostridioides difficileClostridium difficile infectionFMTcapsulelyophilizateprotocol

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.8K
Preparation and Maintenance of Bioexclusion IsoPositive Cage Experiment for Human Fecal Transplantation into Germ-Free Mice07:45

Preparation and Maintenance of Bioexclusion IsoPositive Cage Experiment for Human Fecal Transplantation into Germ-Free Mice

Published on: February 28, 2025

306

Related Concept Videos

Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...